0
21

In This Issue
  |  
FOCUS

Spring 2003, Vol. 1, No. 2
Get Alert | RSS  
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

Editorial
From the Editor
Kathleen T. Brady, M.D., Ph.D.
CLINICAL SYNTHESIS
CME   Evidence-Based Treatments for Substance Use Disorders
Paul B. Gold, Ph.D.; Kathleen T. Brady, M.D., Ph.D.
Quick Reference for Substance-Related Disorders
REVIEW
CME   Substance-Related Disorders
Avram H. Mack, M.D.; Richard J. Frances, M.D.
INFLUENTIAL PUBLICATION
Bibliography for Substance-Related Disorders
Low Level of Brain Dopamine D2 Receptors in Methamphetamine Abusers: Association With Metabolism in the Orbitofrontal Cortex
Nora D. Volkow, M.D.; Linda Chang, M.D.; Gene-Jack Wang, M.D.; Joanna S. Fowler, Ph.D.; Yu-Sin Ding, Ph.D.; Mark Sedler, M.D.; Jean Logan, Ph.D.; Dinko Franceschi, M.D.; John Gatley, Ph.D.; Robert Hitzemann, Ph.D.; Andrew Gifford, Ph.D.; Christopher Wong, M.S.; Naomi Pappas, M.S.
Cannabis Abuse as a Risk Factor for Depressive Symptoms
Gregory B. Bovasso, Ph.D.
Five-Year Clinical Course Associated With DSM-IV Alcohol Abuse or Dependence in a Large Group of Men and Women
Marc A. Schuckit, M.D.; Tom L. Smith, Ph.D.; George P. Danko, Ph.D.; Kathleen K. Bucholz, Ph.D.; Theodore Reich, M.D.; Laura Bierut, M.D.
Evidence for a Gender-Related Effect of Alcoholism on Brain Volumes
Daniel W. Hommer, M.D.; Reza Momenan, Ph.D.; Erica Kaiser, B.A.; Robert R. Rawlings, M.S.
Self-Help Treatment for Combined Addiction and Mental Illness
Marc Galanter, M.D.
Naltrexone and Cognitive Behavioral Therapy for the Treatment of Outpatient Alcoholics: Results of a Placebo-Controlled Trial
Raymond F. Anton, M.D.; Darlene H. Moak, M.D.; L. Randolph Waid, Ph.D.; Patricia K. Latham, R.N., Ph.D.; Robert J. Malcolm, M.D.; James K. Dias, Ph.D.
Addiction Is a Brain Disease, and It Matters
Alan I. Leshner, Ph.D.
Science Is Revolutionizing Our View of Addiction—and What to Do About It
Alan I. Leshner, Ph.D.
Is ADHD a Risk Factor for Psychoactive Substance Use Disorders? Finding From a Four-Year Prospective Follow-Up Study
Joseph Biederman, M.D.; Timothy Wilens, M.D.; Eric Mick, B.A.; Stephen V. Faraone, Ph.D.; Wendy Weber, B.A.; Shannon Curtis, B.A.; Ayanna Thornell, B.A.; Kiffany Pfister, B.A.; Jennifer Garcia Jetton, B.A.; Jennifer Soriano, B.A.
Tests for Drugs of Abuse: The Medical Letter on Drugs and Therapeutics
Monitoring the Future: National Results on Adolescent Drug Use: Overview of Key Findings
Lloyd D. Johnston, Ph.D.; Patrick M. O’Malley, Ph.D.; Jerald G. Bachman, Ph.D.
Clinical Case Conference
When Does Amphetamine-Induced Psychosis Become Schizophrenia?
Michael Flaum, M.D.; Susan K. Schultz, M.D.
  |  
Copyright ©
American
Psychiatric
Association